
Saridegib
CAS No. 1037210-93-7
Saridegib ( Patidegib | IPI-926 )
产品货号. M10185 CAS No. 1037210-93-7
Saridegib (Patidegib, IPI-926) 是一种有效的口服活性 Hedgehog (Hh) 通路拮抗剂,IC50 为 7 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥15957 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Saridegib
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Saridegib (Patidegib, IPI-926) 是一种有效的口服活性 Hedgehog (Hh) 通路拮抗剂,IC50 为 7 nM。
-
产品描述Saridegib (Patidegib, IPI-926) is a potent and orally active Hedgehog (Hh) pathway antagonist with IC50 of 7 nM; binds to and inhibits the cell membrane-spanning G-protein coupled receptor SMO; demonstrates improved pharmaceutical properties and potency and a favorable pharmacokinetic profile relative to cyclopamine and IPI-269609; completely suppresses tumor growth in a Hh-dependent medulloblastoma allograft model.Pancreatic Cancer Phase 2 Clinical.
-
体外实验——
-
体内实验Evidence from a genetically engineered mouse model of pancreatic cancer demonstrates that Saridegib (IPI-926) can deplete tumor-associated stromal tissue and increase intratumoral mean vessel density. These changes result in enhanced delivery of concurrently administered systemic agents, leading to a decreased tumor burden and prolonged survival in this mouse model.
-
同义词Patidegib | IPI-926
-
通路Wnt/Notch/Hedgehog
-
靶点Smoothened (Smo)
-
受体Smoothened (Smo)
-
研究领域Cancer
-
适应症Pancreatic Cancer
化学信息
-
CAS Number1037210-93-7
-
分子量504.768
-
分子式C29H48N2O3S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCS(=O)(N[C@H](CC[C@@]12C)C[C@@]1([H])CC[C@]3([H])[C@]2([H])CC4=C(C)C[C@@](O5)(CC[C@@]34[H])[C@H](C)[C@@]6([H])[C@@]5([H])C[C@H](C)CN6)=O
-
化学全称N-((2S,3R,3aS,3'R,4a'R,6S,6a'R,6b'S,7aR,12a'S,12b'S)-3,6,11',12b'-tetramethyl-2',3a,3',4,4',4a',5,5',6,6',6a',6b',7,7a,7',8',10',12',12a',12b'-icosahydro-1'H,3H-spiro[furo[3,2-b]pyridine-2,9'-naphtho[2,1-a]azulen]-3'-yl)methanesulfonamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Olive KP, et al. Science. 2009 Jun 12;324(5933):1457-61.
2. Tremblay MR, et al. J Med Chem. 2009 Jul 23;52(14):4400-18.
3. Lee MJ, et al. Proc Natl Acad Sci U S A. 2012 May 15;109(20):7859-64.